CD274 and ovarian carcinoma: Further bioinformatics data from TCGA showed that PD-L1 expression was not significantly associated with tumor residual disease, cancer status, venous invasion, lymphatic invasion, tumor grade, and clinical stage, which further suggested that PD-L1 expression was not correlated with advanced clinicopathological characteristics of patients with ovarian cancer.